Sanofi (SNY) Research & Development (2009 - 2026)
Sanofi (SNY) posted Research & Development of -$2.6 billion for the quarter ended Jun 30, 2026, compared with -$2.16 billion a year earlier.
Powered by 
Analysis
Sanofi (SNY) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Sanofi was -$20.26 billion; for the year ended Dec 31, 2025, it was $8.86 billion.
- In prior years, Sanofi's Research & Development was -$8 billion in the year ended Dec 31, 2024, $7.04 billion in the year ended Dec 31, 2023, -$6.85 billion in the year ended Dec 31, 2022 and -$6.74 billion in the year ended Dec 31, 2021.
- Quarterly Research & Development has run from a low of -$9.13 billion in the quarter ended Dec 31, 2025 to a high of -$1.67 billion in the quarter ended Mar 31, 2022 over five years.
- According to Business Quant data, Research & Development for the three prior quarters was -$2.05 billion (quarter ended Mar 31, 2026), -$9.13 billion (quarter ended Dec 31, 2025) and -$6.49 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Sanofi | 50.28 Bn | 17.06 Bn | 10.79 Bn | -2.60 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.60 Bn |
| Mar 31, 2026 | -2.05 Bn |
| Dec 31, 2025 | -9.13 Bn |
| Sep 30, 2025 | -6.49 Bn |
| Jun 30, 2025 | -2.16 Bn |
| Mar 31, 2025 | -1.90 Bn |
| Dec 31, 2024 | -7.90 Bn |
| Sep 30, 2024 | -1.98 Bn |
| Jun 30, 2024 | -1.79 Bn |
| Mar 31, 2024 | -1.81 Bn |
| Dec 31, 2023 | -7.00 Bn |
| Sep 30, 2023 | -1.81 Bn |
| Jun 30, 2023 | -1.77 Bn |
| Mar 31, 2023 | -1.68 Bn |
| Dec 31, 2022 | -6.63 Bn |
| Sep 30, 2022 | -1.75 Bn |
| Jun 30, 2022 | -1.77 Bn |
| Mar 31, 2022 | -1.67 Bn |
| Dec 31, 2021 | -6.51 Bn |
| Sep 30, 2021 | -1.70 Bn |
API Access
Sanofi Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();